24.2 C
Accra
Thursday, September 29, 2022

Coronavirus: Oxford University vaccine trial halted after participant falls ill

Must Read

GBC recognised as trailblazer in development through content

By: Jennifer Frimpong Wiredu The Ghana Broadcasting Corporation, GBC, has been recognised for its role in championing development through its...

GFA suspends 2022/23 Ghana Premier League over court injunction

The Ghana Football Association (GFA), has decided to put the betPawa Premier League on hold. This follows a Motion on...

Nigeria: 18 candidates vying to succeed Buhari

SOURCE:AFRICAN EDITORS Campaigns for Presidential and National Assembly seats officially kicked off Wednesday, Sept 28, in Nigeria. In accordance with Section...

The late-stage COVID-19 candidate vaccine trials run by AstraZeneca have been paused after a participant fell ill.

The company is investigating whether the vaccine recipient’s “potentially unexplained” illness is a result of receiving the shot.

In a statement, AstraZeneca said the “standard review process triggered a pause to vaccination to allow review of safety data” without revealing what the potential side effect of the vaccine was.

AstraZeneca is trialling the Oxford University vaccine which was developed using a chimpanzee adenovirus. The adenovirus was then genetically modified so that it cannot grow in humans.

Typically, the virus causes the common cold in chimpanzees.

The news about the trial’s pause was first reported by health news site STAT, which reported the participant was located in the United Kingdom.

AstraZeneca had been recruiting 30,000 participants in the United States for late-stage trials of the vaccine and is also testing it in thousands of people in the United Kingdom as well as smaller studies in South Africa and Brazil.

Ellie Murray, an epidemiologist at Boston University, wrote on Twitter that determining whether the vaccine produced the illness is why the trial is being stopped. She explained that this was the point of a Phase III trial, stating: “This is the system working.”

The news of the pause came the same day AstraZeneca, along with eight other CEOs, made a pledge to “make the safety and well-being of vaccinated individuals the top priority in development of the first COVID-19 vaccines.”

Sourceeuronews

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News

GBC recognised as trailblazer in development through content

By: Jennifer Frimpong Wiredu The Ghana Broadcasting Corporation, GBC, has been recognised for its role in championing development through its...

GFA suspends 2022/23 Ghana Premier League over court injunction

The Ghana Football Association (GFA), has decided to put the betPawa Premier League on hold. This follows a Motion on Notice for Injunction filed on...

Nigeria: 18 candidates vying to succeed Buhari

SOURCE:AFRICAN EDITORS Campaigns for Presidential and National Assembly seats officially kicked off Wednesday, Sept 28, in Nigeria. In accordance with Section 94(1) of the Electoral Act...

Labour Unions of Public Universities threaten to lay down tools over conditions of service

Leadership of four Labour Unions in the Public Universities in Ghana have given government a week ultimatum to address their conditions of service else,...

Trade between Ghana and China hits US$9.57billion

Built on mutual trust for development, bilateral trade volume between Ghana and China peaked at US$9.57billion in 2021 from US$6.67billion in 2017, the Chinese...

More Articles Like This